SlideShare a Scribd company logo
1 of 25
Measles Outbreak – Pohnpei 2014
Federated States of Micronesia
24 February 2016 -
Colonia, Yap
Overview of data and study design
• Descriptive Cross-sectional study design
• Time frame: May 27, -September-2014
• Data sources
– Line list
– Case reports
– Vaccination records
– Laboratory reports
– Census data
– Hospitalization records
– Death records
Methods of data analysis
 Analysis mainly done on Exel software
 Frequency of cases by date
 Incidence rate by age group and municipality using census
data
 Vaccination coverage using vaccination records 844 and
master list
 Frequency of cases by case type
 Clinical data to verify case definition
 Measles case definition- Acute fever and rash with one or
more of the following; cough, coryza, conjunctivitis
Measles case report form
Measles line list
Epi Overview
• Total cases: 247
• First rash onset date: May 12, 2014
• Last rash onset date: August 2, 2014
– Lab confirmed: 101
– Epi-linked*: 136
– Clinically compatible†: 4
– Lab pending: 6
• Median age: 24 (range: 3 wks, 57 y)
• Female: 47%
• 1 Death
*Residing in same municipality as a lab confirmed case 7-21 days before rash onset
†Rash, fever, and ≥1 “C” AND no or indeterminate lab AND no epi-link
Measles Outbreak Epi-curve, Pohnpei May-August
2014 (n=247)
0
2
4
6
8
10
12
14
16
18
20
Numberofcases
Rash onset date
First case reported
Mass MMR Campaign
First case
Measles Outbreak Epi-curve, Pohnpei May-August 2014
0
2
4
6
8
10
12
14
16
18
20
5/12/2014
5/14/2014
5/16/2014
5/18/2014
5/20/2014
5/22/2014
5/24/2014
5/26/2014
5/28/2014
5/30/2014
6/1/2014
6/3/2014
6/5/2014
6/7/2014
6/9/2014
6/12/2014
6/14/2014
6/16/2014
6/18/2014
6/20/2014
6/22/2014
6/24/2014
6/26/2014
6/28/2014
6/30/2014
7/2/2014
7/4/2014
7/6/2014
7/8/2014
7/10/2014
7/12/2014
7/14/2014
7/16/2014
7/20/2014
7/22/2014
7/24/2014
7/26/2014
7/28/2014
7/30/2014
8/1/2014
Numberofcases
Rash Onset Date
Clinically Compatible
Epi-linked
Pending Lab
Lab confirmed
Clinical presentation of measles cases-Pohnpei May-August 2014
n=247
1
4
4
5
6
7
21
38
50
73
96
100
0 20 40 60 80 100 120
Sorethroat
Bodyache
SOB
Vomiting
Headache
Koplik spots
diarrhea
conjunctivitis
coryza
Cough
Fever
Rash
Percentage
Clinicalpresentation
Proportion of measles cases by municipality, Pohnpei
May-August 2014 (n=247)
KITTI
16%
KOLONIA
23%
MADOLENIHMW
6%
NETT
32%
SOKEHS
15%
U
7%
(blank)
1%
Attack rates by municipality, Pohnpei May-August 2014
n=245
0.0
2.0
4.0
6.0
8.0
10.0
12.0
14.0
KITTI KOLONIA MADOLENIHMW NETT SOKEHS UH
Cummulativeincidenceper1000population
Municipality
Attack rates by age group-Pohnpei Measles Outbreak,
May-August 2014 (n=247)
46.3
6.9
0.2
3.9
13.2
9.5
6.4
1.8
0.0
5.0
10.0
15.0
20.0
25.0
30.0
35.0
40.0
45.0
50.0
<1Y 1-4Y 5-9Y 10-19Y 20-29Y 30-39Y 40-49Y 50-59Y
Cummulativeincidence/1000population
Age group
Vaccination* Status of CasesVaccination Status Count (%)
NOT VACCINATED 54 (22)
UNKNOWN 49 (20)
VACCINATED 110 (45)
(blank) 34 (14)
TOTAL 247 (100)
# Doses Count (%)
Not Vaccinated 64(25.9)
1 Dose 25(10.1)
2 Doses 84(34.0)
3 Doses 7(2.8)
4 Doses 1(0.4)
Unknown 30(12.1)
Pending 36(14.6)
*Vaccination >=7 days before rash onset
• Task Force: EpiNet, FSM Health,PSH, PH
– PH : Mass Measles Vaccination Campaign
– FSM Health: MMR, MR vaccine and Essential
supply
– CDC, WHO, UNICEF: Technical Assistant, VE study
– EpiNet: Surveillance and Case Investigation
– PSH: Treatment for ill/admitted patients- Isolation
Ward
Mobilization of Working group
• Contact tracing and case investigation of confirmed
and suspected measles cases.
• Isolation protocol in place for isolation of suspect
cases at Pohnpei State Hospital
• Vaccination of hospital staff and household
members and contact cases
• Planning, scheduling, and needs estimation for an
emergency vaccination campaign.
• Heightened surveillance for acute fever and rash
• Specimen collection, storage, and shipment to
reference lab for measles testing.
Action:
• Mass Vaccination Campaign:
– MMR, 6mos-24yrs
– MR, 25-49yrs
• Mobilized 7 mobile outreach team and one stationary(PH)
• Pamphlets, awareness/health ed. on sites
• Media-Radio spot, posters, flyers, banner and radio
announcements via AM/FM
• Daily Pohnpei EpiNet meeting to incorporate an action plan
and monitor progress.
• ICS comment system was established and follow through
• Health advisory for Measles developed & disseminated to
Public
Actions Cont.
TYPE TARGET POPULATION COMMENCED
Age Number % of Pop*
Main Non-selective 6 months-49 years 28,492 95.8 June 16, 2014^
Outer Non-selective 6 months-49 years 1,117 79.4 August 12, 2014^
Overall Non-selective 6 months-49 years 30,869 85.8 -
Measles Emergency Mass Vaccination
Campaign in Pohnpei
Abbreviations: FSM, Federated States of Micronesia; Pop, Population
* % of respective (main or outer island) population
•% of overall population Started
•^ Campaign
^ Campaign completed
Note: % of Pohnpei population based on the 2010 census
DOSES VACCINATION COVERAGE
MMR MR Overall Administrative n (%) Assessment(%)*
Main 19,193 9,299 28,492 28,492 (95.8) 86.6
Outer 667 0 667 667 (59.7) None
Overall 19,860 9,299 29,159 29,159 (94.5) -
Vaccination Coverage for MMR and MR Vaccine during
the Emergency Vaccination Campaign on Pohnpei State.
*Rapid Coverage Assessment
Data dissemination and use
•Present results to health authorities,
policy makers, stakeholders
•Present results to stakeholders
•Updated sitrep through PACNET and CDC
•Responding to queries
•Write report and submit for publication
Recommendations
 Ensure clear case definitions are used
 Update and clean data periodically
 Complete case reports
 Timely reporting from sentinel sites
 Timely dissemination of reports to reporting sites and
stakeholder
 Training and engagement of stakeholders
KALAHNGAN

More Related Content

What's hot

Early TB detection and treatment efficiency among MARP's
Early TB detection and treatment efficiency among MARP'sEarly TB detection and treatment efficiency among MARP's
Early TB detection and treatment efficiency among MARP'sZahed Islam
 
Testing Strategies for HIV and HCV: similarities and differences - Dr Chloe O...
Testing Strategies for HIV and HCV: similarities and differences - Dr Chloe O...Testing Strategies for HIV and HCV: similarities and differences - Dr Chloe O...
Testing Strategies for HIV and HCV: similarities and differences - Dr Chloe O...ReShape
 
HCV Treatment Access across Europe - Raquel Peck
HCV Treatment Access across Europe - Raquel PeckHCV Treatment Access across Europe - Raquel Peck
HCV Treatment Access across Europe - Raquel PeckReShape
 
Using telehealth to accelerate biomedical HIV prevention
Using telehealth to accelerate biomedical HIV preventionUsing telehealth to accelerate biomedical HIV prevention
Using telehealth to accelerate biomedical HIV preventionYTH
 

What's hot (20)

Facilitating HIV testing and linkage to care - the UK experience
Facilitating HIV testing and linkage to care - the UK experienceFacilitating HIV testing and linkage to care - the UK experience
Facilitating HIV testing and linkage to care - the UK experience
 
Scaling-up harm reduction services to prevention HIV among people who inject ...
Scaling-up harm reduction services to prevention HIV among people who inject ...Scaling-up harm reduction services to prevention HIV among people who inject ...
Scaling-up harm reduction services to prevention HIV among people who inject ...
 
Scaling up HIV treatment - the Malta experience
Scaling up HIV treatment - the Malta experienceScaling up HIV treatment - the Malta experience
Scaling up HIV treatment - the Malta experience
 
New approaches and new technologies to improve access to HIV testing
New approaches and new technologies to improve access to HIV testingNew approaches and new technologies to improve access to HIV testing
New approaches and new technologies to improve access to HIV testing
 
PrEP implementation strategies across Europe – an overview
PrEP implementation strategies across Europe – an overviewPrEP implementation strategies across Europe – an overview
PrEP implementation strategies across Europe – an overview
 
How are countries in Europe and Central Asia performing against the UNAIDS 90...
How are countries in Europe and Central Asia performing against the UNAIDS 90...How are countries in Europe and Central Asia performing against the UNAIDS 90...
How are countries in Europe and Central Asia performing against the UNAIDS 90...
 
Importance and implication of starting HIV treatment early
Importance and implication of starting HIV treatment earlyImportance and implication of starting HIV treatment early
Importance and implication of starting HIV treatment early
 
Early TB detection and treatment efficiency among MARP's
Early TB detection and treatment efficiency among MARP'sEarly TB detection and treatment efficiency among MARP's
Early TB detection and treatment efficiency among MARP's
 
Testing Strategies for HIV and HCV: similarities and differences - Dr Chloe O...
Testing Strategies for HIV and HCV: similarities and differences - Dr Chloe O...Testing Strategies for HIV and HCV: similarities and differences - Dr Chloe O...
Testing Strategies for HIV and HCV: similarities and differences - Dr Chloe O...
 
Monitoring the EU’s response to the HIV epidemic
Monitoring the EU’s response to  the HIV epidemicMonitoring the EU’s response to  the HIV epidemic
Monitoring the EU’s response to the HIV epidemic
 
Scaling up HIV testing: the role of self-testing
Scaling up HIV testing: the role of self-testingScaling up HIV testing: the role of self-testing
Scaling up HIV testing: the role of self-testing
 
HIV Continuum of Care in the EU/EEA: Findings from Dublin Declaration monitor...
HIV Continuum of Care in the EU/EEA: Findings from Dublin Declaration monitor...HIV Continuum of Care in the EU/EEA: Findings from Dublin Declaration monitor...
HIV Continuum of Care in the EU/EEA: Findings from Dublin Declaration monitor...
 
HCV Treatment Access across Europe - Raquel Peck
HCV Treatment Access across Europe - Raquel PeckHCV Treatment Access across Europe - Raquel Peck
HCV Treatment Access across Europe - Raquel Peck
 
Childhood multidrug-resistant tuberculosis (MDR-TB) in the EU/EEA: an analysi...
Childhood multidrug-resistant tuberculosis (MDR-TB) in the EU/EEA: an analysi...Childhood multidrug-resistant tuberculosis (MDR-TB) in the EU/EEA: an analysi...
Childhood multidrug-resistant tuberculosis (MDR-TB) in the EU/EEA: an analysi...
 
Social determinants and risk factors for tuberculosis; need for harmonisation...
Social determinants and risk factors for tuberculosis; need for harmonisation...Social determinants and risk factors for tuberculosis; need for harmonisation...
Social determinants and risk factors for tuberculosis; need for harmonisation...
 
World Tuberculosis Day 2017 - Tuberculosis situation in the EU/EEA, 2015
World Tuberculosis Day 2017 - Tuberculosis situation in the EU/EEA, 2015 World Tuberculosis Day 2017 - Tuberculosis situation in the EU/EEA, 2015
World Tuberculosis Day 2017 - Tuberculosis situation in the EU/EEA, 2015
 
How can HIV among men who have sex with men be prevented in Europe? Evidence-...
How can HIV among men who have sex with men be prevented in Europe? Evidence-...How can HIV among men who have sex with men be prevented in Europe? Evidence-...
How can HIV among men who have sex with men be prevented in Europe? Evidence-...
 
ECDC Survey on IIS in the EU/EEA
ECDC Survey on IIS in the EU/EEAECDC Survey on IIS in the EU/EEA
ECDC Survey on IIS in the EU/EEA
 
HIV: epidemiological challenges in Europe
HIV: epidemiological challenges in Europe HIV: epidemiological challenges in Europe
HIV: epidemiological challenges in Europe
 
Using telehealth to accelerate biomedical HIV prevention
Using telehealth to accelerate biomedical HIV preventionUsing telehealth to accelerate biomedical HIV prevention
Using telehealth to accelerate biomedical HIV prevention
 

Viewers also liked

DSI Brochure March 2016
DSI Brochure March 2016DSI Brochure March 2016
DSI Brochure March 2016JoBeth White
 
Practise and politics the second social realism homework
Practise and politics the second social realism homeworkPractise and politics the second social realism homework
Practise and politics the second social realism homeworkBishop2000
 
Your favourite vintage and craft shop - Everlasting Now, Oakham
Your favourite vintage and craft shop - Everlasting Now, OakhamYour favourite vintage and craft shop - Everlasting Now, Oakham
Your favourite vintage and craft shop - Everlasting Now, OakhamLorna Vibert
 
The Claire Booker Way
The Claire Booker WayThe Claire Booker Way
The Claire Booker WayTed Brannon
 
Top 8 qa director resume samples
Top 8 qa director resume samplesTop 8 qa director resume samples
Top 8 qa director resume samplestonychoper1905
 
Practise and politics
Practise and politicsPractise and politics
Practise and politicsBishop2000
 
Sara's Erasmus in Valencia
Sara's Erasmus in ValenciaSara's Erasmus in Valencia
Sara's Erasmus in ValenciaLuisella Mori
 
Key elements in a film introduction
Key elements in a film introductionKey elements in a film introduction
Key elements in a film introductionBishop2000
 
Documento sin título
Documento sin títuloDocumento sin título
Documento sin títulovictoriaabad
 
Sesión Académica del CRAIC: Dermatomiositis, polimiositis y vasculitis
Sesión Académica del CRAIC: Dermatomiositis, polimiositis y vasculitisSesión Académica del CRAIC: Dermatomiositis, polimiositis y vasculitis
Sesión Académica del CRAIC: Dermatomiositis, polimiositis y vasculitisJuan Carlos Ivancevich
 
Cuidado de manos y pies x sandra
Cuidado de manos y pies x sandraCuidado de manos y pies x sandra
Cuidado de manos y pies x sandrasasiva88
 
Asepsia, antisepsia y esterilidad en cirugía bucal
Asepsia, antisepsia y esterilidad en cirugía bucalAsepsia, antisepsia y esterilidad en cirugía bucal
Asepsia, antisepsia y esterilidad en cirugía bucalJorge Luis Rivas Galindo
 

Viewers also liked (18)

Mecanismos propuesta
Mecanismos propuestaMecanismos propuesta
Mecanismos propuesta
 
Class seven namaz
Class seven namazClass seven namaz
Class seven namaz
 
DSI Brochure March 2016
DSI Brochure March 2016DSI Brochure March 2016
DSI Brochure March 2016
 
Practise and politics the second social realism homework
Practise and politics the second social realism homeworkPractise and politics the second social realism homework
Practise and politics the second social realism homework
 
5206
52065206
5206
 
charlie chaplinPaso 2
charlie chaplinPaso 2charlie chaplinPaso 2
charlie chaplinPaso 2
 
Your favourite vintage and craft shop - Everlasting Now, Oakham
Your favourite vintage and craft shop - Everlasting Now, OakhamYour favourite vintage and craft shop - Everlasting Now, Oakham
Your favourite vintage and craft shop - Everlasting Now, Oakham
 
The Claire Booker Way
The Claire Booker WayThe Claire Booker Way
The Claire Booker Way
 
Top 8 qa director resume samples
Top 8 qa director resume samplesTop 8 qa director resume samples
Top 8 qa director resume samples
 
PRUEBAS SABER
PRUEBAS SABERPRUEBAS SABER
PRUEBAS SABER
 
Bel Ami
Bel AmiBel Ami
Bel Ami
 
Practise and politics
Practise and politicsPractise and politics
Practise and politics
 
Sara's Erasmus in Valencia
Sara's Erasmus in ValenciaSara's Erasmus in Valencia
Sara's Erasmus in Valencia
 
Key elements in a film introduction
Key elements in a film introductionKey elements in a film introduction
Key elements in a film introduction
 
Documento sin título
Documento sin títuloDocumento sin título
Documento sin título
 
Sesión Académica del CRAIC: Dermatomiositis, polimiositis y vasculitis
Sesión Académica del CRAIC: Dermatomiositis, polimiositis y vasculitisSesión Académica del CRAIC: Dermatomiositis, polimiositis y vasculitis
Sesión Académica del CRAIC: Dermatomiositis, polimiositis y vasculitis
 
Cuidado de manos y pies x sandra
Cuidado de manos y pies x sandraCuidado de manos y pies x sandra
Cuidado de manos y pies x sandra
 
Asepsia, antisepsia y esterilidad en cirugía bucal
Asepsia, antisepsia y esterilidad en cirugía bucalAsepsia, antisepsia y esterilidad en cirugía bucal
Asepsia, antisepsia y esterilidad en cirugía bucal
 

Similar to Measles_Outbreak_–_Pohnpei

guidelinesmeasuringpopulation
guidelinesmeasuringpopulationguidelinesmeasuringpopulation
guidelinesmeasuringpopulationVelma Lopez
 
Ri in ut of puducherry success story of sepio dr.sudha goel
Ri in ut of puducherry  success story of sepio dr.sudha goelRi in ut of puducherry  success story of sepio dr.sudha goel
Ri in ut of puducherry success story of sepio dr.sudha goelSudha Goel
 
Surveillance of emerging diseases and networks.
Surveillance of emerging diseases and networks.Surveillance of emerging diseases and networks.
Surveillance of emerging diseases and networks.Jean Jacques Bernatas
 
Final_CBoW_Presentation_By_Belay_Regassa.pdf
Final_CBoW_Presentation_By_Belay_Regassa.pdfFinal_CBoW_Presentation_By_Belay_Regassa.pdf
Final_CBoW_Presentation_By_Belay_Regassa.pdfBelay Regassa
 
SURVEILLANCE OF HEALTH EVENT
SURVEILLANCE OF HEALTH EVENTSURVEILLANCE OF HEALTH EVENT
SURVEILLANCE OF HEALTH EVENTAneesa K Ayoob
 
Trends on Health-Care Associated Infections and Infection Control in Estonia ...
Trends on Health-Care Associated Infections and Infection Control in Estonia ...Trends on Health-Care Associated Infections and Infection Control in Estonia ...
Trends on Health-Care Associated Infections and Infection Control in Estonia ...Kazimierz Murzyn
 
1.HIV Background and Epidemiology - Copy (2).ppt
1.HIV Background and Epidemiology - Copy (2).ppt1.HIV Background and Epidemiology - Copy (2).ppt
1.HIV Background and Epidemiology - Copy (2).pptssuser0c2aba
 
1. IDSP - Overview.pptx
1. IDSP - Overview.pptx1. IDSP - Overview.pptx
1. IDSP - Overview.pptxvijinandu1
 
Pestforecast: Surveillance and early warning systems for climate sensitive di...
Pestforecast: Surveillance and early warning systems for climate sensitive di...Pestforecast: Surveillance and early warning systems for climate sensitive di...
Pestforecast: Surveillance and early warning systems for climate sensitive di...ILRI
 
Update on PDPH Strategic Plan – Sexual Health
Update on PDPH Strategic Plan – Sexual HealthUpdate on PDPH Strategic Plan – Sexual Health
Update on PDPH Strategic Plan – Sexual HealthOffice of HIV Planning
 
Vaccination coverage and reasons for non-vaccination after a MVC
Vaccination coverage and reasons for non-vaccination after a MVCVaccination coverage and reasons for non-vaccination after a MVC
Vaccination coverage and reasons for non-vaccination after a MVCTheocharopoulos Georgios Yorgos
 
Dasar dasar Surveilan.pptx
Dasar dasar Surveilan.pptxDasar dasar Surveilan.pptx
Dasar dasar Surveilan.pptxssuser1280ab
 
Iowa TelePrEP: Delivering PrEP through Telemedicine and Public Health Partner...
Iowa TelePrEP: Delivering PrEP through Telemedicine and Public Health Partner...Iowa TelePrEP: Delivering PrEP through Telemedicine and Public Health Partner...
Iowa TelePrEP: Delivering PrEP through Telemedicine and Public Health Partner...YTH
 
Iowa TelePrEP: Delivering PrEP through Telemedicine and Public Health Partner...
Iowa TelePrEP: Delivering PrEP through Telemedicine and Public Health Partner...Iowa TelePrEP: Delivering PrEP through Telemedicine and Public Health Partner...
Iowa TelePrEP: Delivering PrEP through Telemedicine and Public Health Partner...YTH
 
Leveraging Text Classification Strategies for Clinical and Public Health Appl...
Leveraging Text Classification Strategies for Clinical and Public Health Appl...Leveraging Text Classification Strategies for Clinical and Public Health Appl...
Leveraging Text Classification Strategies for Clinical and Public Health Appl...Karin Verspoor
 
Measles surveillance sepio mtg 18 20 may 2011 (ab) v1
Measles surveillance sepio mtg 18 20 may 2011 (ab) v1Measles surveillance sepio mtg 18 20 may 2011 (ab) v1
Measles surveillance sepio mtg 18 20 may 2011 (ab) v1Prabir Chatterjee
 
Institut Pasteur: An International Partner To Implement One Health Maria VA...
Institut Pasteur: An International Partner To Implement One Health   Maria VA...Institut Pasteur: An International Partner To Implement One Health   Maria VA...
Institut Pasteur: An International Partner To Implement One Health Maria VA...Global Risk Forum GRFDavos
 
Public Health England: Public awareness and opinion survey 2016
Public Health England: Public awareness and opinion survey 2016Public Health England: Public awareness and opinion survey 2016
Public Health England: Public awareness and opinion survey 2016Ipsos UK
 
Danish experience in tackling AMR
Danish experience in tackling AMRDanish experience in tackling AMR
Danish experience in tackling AMRTHL
 

Similar to Measles_Outbreak_–_Pohnpei (20)

guidelinesmeasuringpopulation
guidelinesmeasuringpopulationguidelinesmeasuringpopulation
guidelinesmeasuringpopulation
 
Ri in ut of puducherry success story of sepio dr.sudha goel
Ri in ut of puducherry  success story of sepio dr.sudha goelRi in ut of puducherry  success story of sepio dr.sudha goel
Ri in ut of puducherry success story of sepio dr.sudha goel
 
Surveillance of emerging diseases and networks.
Surveillance of emerging diseases and networks.Surveillance of emerging diseases and networks.
Surveillance of emerging diseases and networks.
 
Final_CBoW_Presentation_By_Belay_Regassa.pdf
Final_CBoW_Presentation_By_Belay_Regassa.pdfFinal_CBoW_Presentation_By_Belay_Regassa.pdf
Final_CBoW_Presentation_By_Belay_Regassa.pdf
 
SURVEILLANCE OF HEALTH EVENT
SURVEILLANCE OF HEALTH EVENTSURVEILLANCE OF HEALTH EVENT
SURVEILLANCE OF HEALTH EVENT
 
Trends on Health-Care Associated Infections and Infection Control in Estonia ...
Trends on Health-Care Associated Infections and Infection Control in Estonia ...Trends on Health-Care Associated Infections and Infection Control in Estonia ...
Trends on Health-Care Associated Infections and Infection Control in Estonia ...
 
HIV and pregnancy
HIV and pregnancyHIV and pregnancy
HIV and pregnancy
 
1.HIV Background and Epidemiology - Copy (2).ppt
1.HIV Background and Epidemiology - Copy (2).ppt1.HIV Background and Epidemiology - Copy (2).ppt
1.HIV Background and Epidemiology - Copy (2).ppt
 
1. IDSP - Overview.pptx
1. IDSP - Overview.pptx1. IDSP - Overview.pptx
1. IDSP - Overview.pptx
 
Pestforecast: Surveillance and early warning systems for climate sensitive di...
Pestforecast: Surveillance and early warning systems for climate sensitive di...Pestforecast: Surveillance and early warning systems for climate sensitive di...
Pestforecast: Surveillance and early warning systems for climate sensitive di...
 
Update on PDPH Strategic Plan – Sexual Health
Update on PDPH Strategic Plan – Sexual HealthUpdate on PDPH Strategic Plan – Sexual Health
Update on PDPH Strategic Plan – Sexual Health
 
Vaccination coverage and reasons for non-vaccination after a MVC
Vaccination coverage and reasons for non-vaccination after a MVCVaccination coverage and reasons for non-vaccination after a MVC
Vaccination coverage and reasons for non-vaccination after a MVC
 
Dasar dasar Surveilan.pptx
Dasar dasar Surveilan.pptxDasar dasar Surveilan.pptx
Dasar dasar Surveilan.pptx
 
Iowa TelePrEP: Delivering PrEP through Telemedicine and Public Health Partner...
Iowa TelePrEP: Delivering PrEP through Telemedicine and Public Health Partner...Iowa TelePrEP: Delivering PrEP through Telemedicine and Public Health Partner...
Iowa TelePrEP: Delivering PrEP through Telemedicine and Public Health Partner...
 
Iowa TelePrEP: Delivering PrEP through Telemedicine and Public Health Partner...
Iowa TelePrEP: Delivering PrEP through Telemedicine and Public Health Partner...Iowa TelePrEP: Delivering PrEP through Telemedicine and Public Health Partner...
Iowa TelePrEP: Delivering PrEP through Telemedicine and Public Health Partner...
 
Leveraging Text Classification Strategies for Clinical and Public Health Appl...
Leveraging Text Classification Strategies for Clinical and Public Health Appl...Leveraging Text Classification Strategies for Clinical and Public Health Appl...
Leveraging Text Classification Strategies for Clinical and Public Health Appl...
 
Measles surveillance sepio mtg 18 20 may 2011 (ab) v1
Measles surveillance sepio mtg 18 20 may 2011 (ab) v1Measles surveillance sepio mtg 18 20 may 2011 (ab) v1
Measles surveillance sepio mtg 18 20 may 2011 (ab) v1
 
Institut Pasteur: An International Partner To Implement One Health Maria VA...
Institut Pasteur: An International Partner To Implement One Health   Maria VA...Institut Pasteur: An International Partner To Implement One Health   Maria VA...
Institut Pasteur: An International Partner To Implement One Health Maria VA...
 
Public Health England: Public awareness and opinion survey 2016
Public Health England: Public awareness and opinion survey 2016Public Health England: Public awareness and opinion survey 2016
Public Health England: Public awareness and opinion survey 2016
 
Danish experience in tackling AMR
Danish experience in tackling AMRDanish experience in tackling AMR
Danish experience in tackling AMR
 

Measles_Outbreak_–_Pohnpei

  • 1. Measles Outbreak – Pohnpei 2014 Federated States of Micronesia 24 February 2016 - Colonia, Yap
  • 2. Overview of data and study design • Descriptive Cross-sectional study design • Time frame: May 27, -September-2014 • Data sources – Line list – Case reports – Vaccination records – Laboratory reports – Census data – Hospitalization records – Death records
  • 3. Methods of data analysis  Analysis mainly done on Exel software  Frequency of cases by date  Incidence rate by age group and municipality using census data  Vaccination coverage using vaccination records 844 and master list  Frequency of cases by case type  Clinical data to verify case definition  Measles case definition- Acute fever and rash with one or more of the following; cough, coryza, conjunctivitis
  • 6. Epi Overview • Total cases: 247 • First rash onset date: May 12, 2014 • Last rash onset date: August 2, 2014 – Lab confirmed: 101 – Epi-linked*: 136 – Clinically compatible†: 4 – Lab pending: 6 • Median age: 24 (range: 3 wks, 57 y) • Female: 47% • 1 Death *Residing in same municipality as a lab confirmed case 7-21 days before rash onset †Rash, fever, and ≥1 “C” AND no or indeterminate lab AND no epi-link
  • 7. Measles Outbreak Epi-curve, Pohnpei May-August 2014 (n=247) 0 2 4 6 8 10 12 14 16 18 20 Numberofcases Rash onset date First case reported Mass MMR Campaign
  • 9. Measles Outbreak Epi-curve, Pohnpei May-August 2014 0 2 4 6 8 10 12 14 16 18 20 5/12/2014 5/14/2014 5/16/2014 5/18/2014 5/20/2014 5/22/2014 5/24/2014 5/26/2014 5/28/2014 5/30/2014 6/1/2014 6/3/2014 6/5/2014 6/7/2014 6/9/2014 6/12/2014 6/14/2014 6/16/2014 6/18/2014 6/20/2014 6/22/2014 6/24/2014 6/26/2014 6/28/2014 6/30/2014 7/2/2014 7/4/2014 7/6/2014 7/8/2014 7/10/2014 7/12/2014 7/14/2014 7/16/2014 7/20/2014 7/22/2014 7/24/2014 7/26/2014 7/28/2014 7/30/2014 8/1/2014 Numberofcases Rash Onset Date Clinically Compatible Epi-linked Pending Lab Lab confirmed
  • 10. Clinical presentation of measles cases-Pohnpei May-August 2014 n=247 1 4 4 5 6 7 21 38 50 73 96 100 0 20 40 60 80 100 120 Sorethroat Bodyache SOB Vomiting Headache Koplik spots diarrhea conjunctivitis coryza Cough Fever Rash Percentage Clinicalpresentation
  • 11. Proportion of measles cases by municipality, Pohnpei May-August 2014 (n=247) KITTI 16% KOLONIA 23% MADOLENIHMW 6% NETT 32% SOKEHS 15% U 7% (blank) 1%
  • 12. Attack rates by municipality, Pohnpei May-August 2014 n=245 0.0 2.0 4.0 6.0 8.0 10.0 12.0 14.0 KITTI KOLONIA MADOLENIHMW NETT SOKEHS UH Cummulativeincidenceper1000population Municipality
  • 13. Attack rates by age group-Pohnpei Measles Outbreak, May-August 2014 (n=247) 46.3 6.9 0.2 3.9 13.2 9.5 6.4 1.8 0.0 5.0 10.0 15.0 20.0 25.0 30.0 35.0 40.0 45.0 50.0 <1Y 1-4Y 5-9Y 10-19Y 20-29Y 30-39Y 40-49Y 50-59Y Cummulativeincidence/1000population Age group
  • 14. Vaccination* Status of CasesVaccination Status Count (%) NOT VACCINATED 54 (22) UNKNOWN 49 (20) VACCINATED 110 (45) (blank) 34 (14) TOTAL 247 (100) # Doses Count (%) Not Vaccinated 64(25.9) 1 Dose 25(10.1) 2 Doses 84(34.0) 3 Doses 7(2.8) 4 Doses 1(0.4) Unknown 30(12.1) Pending 36(14.6) *Vaccination >=7 days before rash onset
  • 15.
  • 16. • Task Force: EpiNet, FSM Health,PSH, PH – PH : Mass Measles Vaccination Campaign – FSM Health: MMR, MR vaccine and Essential supply – CDC, WHO, UNICEF: Technical Assistant, VE study – EpiNet: Surveillance and Case Investigation – PSH: Treatment for ill/admitted patients- Isolation Ward Mobilization of Working group
  • 17. • Contact tracing and case investigation of confirmed and suspected measles cases. • Isolation protocol in place for isolation of suspect cases at Pohnpei State Hospital • Vaccination of hospital staff and household members and contact cases • Planning, scheduling, and needs estimation for an emergency vaccination campaign. • Heightened surveillance for acute fever and rash • Specimen collection, storage, and shipment to reference lab for measles testing. Action:
  • 18. • Mass Vaccination Campaign: – MMR, 6mos-24yrs – MR, 25-49yrs • Mobilized 7 mobile outreach team and one stationary(PH) • Pamphlets, awareness/health ed. on sites • Media-Radio spot, posters, flyers, banner and radio announcements via AM/FM • Daily Pohnpei EpiNet meeting to incorporate an action plan and monitor progress. • ICS comment system was established and follow through • Health advisory for Measles developed & disseminated to Public Actions Cont.
  • 19. TYPE TARGET POPULATION COMMENCED Age Number % of Pop* Main Non-selective 6 months-49 years 28,492 95.8 June 16, 2014^ Outer Non-selective 6 months-49 years 1,117 79.4 August 12, 2014^ Overall Non-selective 6 months-49 years 30,869 85.8 - Measles Emergency Mass Vaccination Campaign in Pohnpei Abbreviations: FSM, Federated States of Micronesia; Pop, Population * % of respective (main or outer island) population •% of overall population Started •^ Campaign ^ Campaign completed Note: % of Pohnpei population based on the 2010 census
  • 20. DOSES VACCINATION COVERAGE MMR MR Overall Administrative n (%) Assessment(%)* Main 19,193 9,299 28,492 28,492 (95.8) 86.6 Outer 667 0 667 667 (59.7) None Overall 19,860 9,299 29,159 29,159 (94.5) - Vaccination Coverage for MMR and MR Vaccine during the Emergency Vaccination Campaign on Pohnpei State. *Rapid Coverage Assessment
  • 21.
  • 22.
  • 23. Data dissemination and use •Present results to health authorities, policy makers, stakeholders •Present results to stakeholders •Updated sitrep through PACNET and CDC •Responding to queries •Write report and submit for publication
  • 24. Recommendations  Ensure clear case definitions are used  Update and clean data periodically  Complete case reports  Timely reporting from sentinel sites  Timely dissemination of reports to reporting sites and stakeholder  Training and engagement of stakeholders